Yanxiu Li1, Iokfai Cheang2, Zhongwen Zhang3, Wenming Yao2, Yanli Zhou2, Haifeng Zhang2, Yun Liu1, Xiangrong Zuo1, Xinli Li2, Quan Cao1. 1. Department of Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. 2. Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. 3. Department of General Surgery, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Abstract
Background: Telomere length and telomerase are associated in development of cardiovascular diseases. Study aims to investigate the associations of TERC and TERT gene polymorphism and leukocyte telomere length (LTL) in the prognosis of acute heart failure (AHF). Methods: Total 322 patients with AHF were enrolled and divided into death and survival group according to all-cause mortality within 18 months. Seven single nucleotide polymorphisms (SNPs) of TERC and TERT were selected. Baseline characteristics, genotype distribution and polymorphic allele frequency, and genetic model were initially analyzed. Genotypes and the LTL were determined for further analysis. Results: Compared to carrying homozygous wild genotype, the risk of death in patients with mutated alleles of four SNPs- rs12696304(G>C), rs10936599(T>C), rs1317082(G>A), and rs10936601(T>C) of TERC were significantly higher. The dominant models of above were independently associated with mortality. In recessive models, rs10936599 and rs1317082 of TERC, rs7726159 of TERT were independently associated with long-term mortality. Further analysis showed, in haplotype consisting with TERC - rs12696304, rs10936599, rs1317082, and rs10936601, mutant alleles CCAC and wild alleles GTGT were significant difference between groups (P<0.05). CCAC is a risk factor and GTGT is a protective factor for AHF patients. Relative LTL decreased over age, but showed no difference between groups and genotypes. Conclusions: The SNPs of TERC and TERT are associated with the prognosis of AHF, and are the independent risk factors for predicting 18-month mortality in AHF.
Background: Telomere length and telomerase are associated in development of cardiovascular diseases. Study aims to investigate the associations of TERC and TERT gene polymorphism and leukocyte telomere length (LTL) in the prognosis of acute heart failure (AHF). Methods: Total 322 patients with AHF were enrolled and divided into death and survival group according to all-cause mortality within 18 months. Seven single nucleotide polymorphisms (SNPs) of TERC and TERT were selected. Baseline characteristics, genotype distribution and polymorphic allele frequency, and genetic model were initially analyzed. Genotypes and the LTL were determined for further analysis. Results: Compared to carrying homozygous wild genotype, the risk of death in patients with mutated alleles of four SNPs- rs12696304(G>C), rs10936599(T>C), rs1317082(G>A), and rs10936601(T>C) of TERC were significantly higher. The dominant models of above were independently associated with mortality. In recessive models, rs10936599 and rs1317082 of TERC, rs7726159 of TERT were independently associated with long-term mortality. Further analysis showed, in haplotype consisting with TERC - rs12696304, rs10936599, rs1317082, and rs10936601, mutant alleles CCAC and wild alleles GTGT were significant difference between groups (P<0.05). CCAC is a risk factor and GTGT is a protective factor for AHF patients. Relative LTL decreased over age, but showed no difference between groups and genotypes. Conclusions: The SNPs of TERC and TERT are associated with the prognosis of AHF, and are the independent risk factors for predicting 18-month mortality in AHF.
Authors: T von Zglinicki; V Serra; M Lorenz; G Saretzki; R Lenzen-Grossimlighaus; R Gessner; A Risch; E Steinhagen-Thiessen Journal: Lab Invest Date: 2000-11 Impact factor: 5.662
Authors: Charles Matthews; Isabelle Gorenne; Stephen Scott; Nicola Figg; Peter Kirkpatrick; Andrew Ritchie; Martin Goddard; Martin Bennett Journal: Circ Res Date: 2006-06-22 Impact factor: 17.367
Authors: Stanford Mwasongwe; Yan Gao; Michael Griswold; James G Wilson; Abraham Aviv; Alexander P Reiner; Laura M Raffield Journal: Atherosclerosis Date: 2017-09-15 Impact factor: 5.162
Authors: Jiankang Liu; Caroline S Fox; DeMarc A Hickson; Warren D May; Kristen G Hairston; J Jeffery Carr; Herman A Taylor Journal: J Clin Endocrinol Metab Date: 2010-09-15 Impact factor: 5.958
Authors: Jose-Angel Perez-Rivera; Pedro Pabon-Osuna; Clara Cieza-Borrella; Olga Duran-Bobin; Francisco Martin-Herrero; Jose-Ramon Gonzalez-Porras; Rogelio Gonzalez-Sarmiento Journal: Am J Cardiol Date: 2013-11-07 Impact factor: 2.778
Authors: A V Kazantseva; Yu D Davydova; R F Enikeeva; R N Mustafin; M M Lobaskova; S B Malykh; E K Khusnutdinova Journal: Russ J Genet Date: 2022-09-13 Impact factor: 0.691